Trial Profile
Fesoterodine in Patients with Overactive Bladder Syndrome; Potential Biomarkers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics; Therapeutic Use
- 27 Oct 2015 published in Yonsei Med J. 2015 Jan;56(1):204-211
- 27 Oct 2015 New trial record